DC Devices Inc.
Pressure-relieving implant for HF patients
This article was originally published in Start Up
Executive Summary
DC Devices Inc. has developed the first transcatheter, permanent implant for treating heart failure with preserved ejection fraction. The implant, placed in the atrial septum, creates a small, controlled shunt, allowing blood to move from the higher-pressure left atrium to the lower pressure, more compliant right atrium; this serves to reduce left atrial pressure and relieve HF symptoms, without compromising cardiac output.